An Act helping overdosing persons in emergencies
Generates a plain-language summary of the bill text and history.
| Date | Branch | Action |
|---|---|---|
| 11/6/2025 | Senate | Bill reported favorably by committee and referred to the committee on Senate Ways and Means |
| 8/7/2025 | Joint | Hearing scheduled for 09/15/2025 from 11:00 AM-05:00 PM in Gardner Auditorium |
| 2/27/2025 | House | House concurred |
| 2/27/2025 | Senate | Referred to the committee on Mental Health, Substance Use and Recovery |
| Committee | Recommendation | Vote |
|---|---|---|
| J18 | Favorable | 1 entries |
Section 1 of chapter 94C of the General Laws, as appearing in the 2020 Official Edition, is hereby amended by inserting after the definition of “Opiate” the following definition:- “Opioid antagonist”, a drug, including but not limited to naloxone, approved by the federal Food and Drug Administration for the complete or partial reversal of an opioid or opiate overdose.
Section 34A of chapter 94C of the General Laws, as appearing in the 2018 Official Edition, is hereby amended by inserting at the end thereof the following 2 subsections:- f) State and municipal law enforcement personnel and emergency medical personnel including, but not limited to, emergency medical technicians, paramedics, and fire department personnel may provide and transfer an opioid antagonist to an individual or to an individual’s family member, friend, or other person with knowledge of an individual’s prior substance use, along with instructions on administration and use of the opioid antagonist, to provide opioid overdose protection to an individual. The provision and transfer of an opioid antagonist shall be based upon the good faith judgement of the law enforcement or emergency medical personnel including but not limited to their experience, training, knowledge, observations and the information provided by an individual at substantial risk of experiencing an opioid-related overdose event or from an individual’s family, friend or others with knowledge of an individual’s prior opioid use; provided, however, that such provision or transfer of opioid antagonists shall be subject such drug’s availability; provided further, that a governmental entity or organization that employs such law enforcement and emergency medical personnel may promulgate or implement reasonable rules or regulations concerning such provision or transfer. (g) A person acting in good faith may provide, administer or utilize testing equipment to assist another person in identifying or analyzing the strength, effectiveness or purity of a controlled substance. A person who, in good faith, provides, administers or utilizes testing equipment to assist another person in identifying or in analyzing the strength, effectiveness or purity of a controlled substance shall not be charged or prosecuted for possession of a controlled substance under section 34 or possession of drug paraphernalia under section 32I. Testing equipment shall include, but not be limited to, fentanyl test strips, colorimetric reagents, high-performance liquid chromatography, gas chromatography and mass spectrometry.
Section 201 of chapter 111 of the General Laws, as so appearing, is hereby amended by inserting after the first paragraph the following paragraph:- First aid training required under this section shall include instruction on how to administer opioid antagonists, in overdose emergencies. The training for the administration of opioid antagonists shall meet the standards prescribed by the department. Required personnel shall satisfactorily complete an initial instruction as soon as practical, but in no event more than 1 year after the start date of their employment. Notwithstanding the foregoing, required personnel who began their employment before the effective date of the training requirement prescribed under this paragraph shall satisfactorily complete their instruction as soon as practical, but in no event more than 1 year after said effective date. Satisfactory completion of a refresher course in administering opioid antagonists as approved by the department shall be required every 3 years, unless the department establishes an earlier time requirement by regulation.
Said chapter 111, as so appearing, is hereby further amended by inserting after section 201, the following section:-
½. (a) As used in this section, the following words, unless the context clearly requires otherwise, shall have the following meanings:- “Emergency first response vehicle”, any official government motor vehicle and motorized watercraft that is intended and primarily operated to provide for the transport and rapid response of first responders to emergencies involving the public. “First responders”, members of police and fire departments, members of the state police participating in highway patrol, and members of emergency reserve units of a volunteer fire department or fire protection district, who are trained to administer an opioid antagonist pursuant to the first aid training requirements under section 201; provided, however, that first responders shall not include police officers, fire department personnel and persons engaged in police and fire work whose duties are primarily clerical or administrative. “Opioid antagonist”, as defined in section 1 of chapter 94C. (b) A governmental entity or organization shall be responsible to provide on duty first responders with an opioid antagonist for use in opioid overdose emergencies. This requirement shall be complied with by implementing 1, or any part or combination, of the following methods: (i) equipping emergency first response vehicles under its ownership, care or control with an opioid antagonist; or (ii) supplying an opioid antagonist to its first responders to be carried by such persons when on duty; provided, however, that replacement doses are made available no less than 48 hours following the administration of the last remaining dose of opioid antagonist provided by the government entity or organization to the first responder or made available in the emergency first response vehicle. (c) The requirement of a government entity or organization to provide its first responders with an opioid antagonist under this section, shall be subject to such drug’s availability, provided the government entity or organization has taken reasonable measures, as soon as practicable, to acquire and replenish its supply of an obtainable opioid antagonist to comply with this requirement. (d) No cost shall be assessed to first responders by their employing or appointing governmental entity or organization for any opioid antagonist required under this section to be supplied or made available to first responders, including any device necessary for first responders to carry the drug when on duty, which shall be provided by such entity or organization. (e) The immunity provisions established under subsection (g) of section 19B and 34A of chapter 94C shall also apply to first responders who administer an opioid antagonist.
Subsections (b) through (d), inclusive, of Section 4 shall take effect 8 months after the passage of this act.
SECTION 1. Section 1 of chapter 94C of the General Laws, as appearing in the 2020 Official Edition, is hereby amended by inserting after the definition of “Opiate” the following definition:- “Opioid antagonist”, a drug, including but not limited to naloxone, approved by the federal Food and Drug Administration for the complete or partial reversal of an opioid or opiate overdose. SECTION 2. Section 34A of chapter 94C of the General Laws, as appearing in the 2018 Official Edition, is hereby amended by inserting at the end thereof the following 2 subsections:- f) State and municipal law enforcement personnel and emergency medical personnel including, but not limited to, emergency medical technicians, paramedics, and fire department personnel may provide and transfer an opioid antagonist to an individual or to an individual’s family member, friend, or other person with knowledge of an individual’s prior substance use, along with instructions on administration and use of the opioid antagonist, to provide opioid overdose protection to an individual. The provision and transfer of an opioid antagonist shall be based upon the good faith judgement of the law enforcement or emergency medical personnel including but not limited to their experience, training, knowledge, observations and the information provided by an individual at substantial risk of experiencing an opioid-related overdose event or from an individual’s family, friend or others with knowledge of an individual’s prior opioid use; provided, however, that such provision or transfer of opioid antagonists shall be subject such drug’s availability; provided further, that a governmental entity or organization that employs such law enforcement and emergency medical personnel may promulgate or implement reasonable rules or regulations concerning such provision or transfer. (g) A person acting in good faith may provide, administer or utilize testing equipment to assist another person in identifying or analyzing the strength, effectiveness or purity of a controlled substance. A person who, in good faith, provides, administers or utilizes testing equipment to assist another person in identifying or in analyzing the strength, effectiveness or purity of a controlled substance shall not be charged or prosecuted for possession of a controlled substance under section 34 or possession of drug paraphernalia under section 32I. Testing equipment shall include, but not be limited to, fentanyl test strips, colorimetric reagents, high-performance liquid chromatography, gas chromatography and mass spectrometry. SECTION 3. Section 201 of chapter 111 of the General Laws, as so appearing, is hereby amended by inserting after the first paragraph the following paragraph:- First aid training required under this section shall include instruction on how to administer opioid antagonists, in overdose emergencies. The training for the administration of opioid antagonists shall meet the standards prescribed by the department. Required personnel shall satisfactorily complete an initial instruction as soon as practical, but in no event more than 1 year after the start date of their employment. Notwithstanding the foregoing, required personnel who began their employment before the effective date of the training requirement prescribed under this paragraph shall satisfactorily complete their instruction as soon as practical, but in no event more than 1 year after said effective date. Satisfactory completion of a refresher course in administering opioid antagonists as approved by the department shall be required every 3 years, unless the department establishes an earlier time requirement by regulation. SECTION 4. Said chapter 111, as so appearing, is hereby further amended by inserting after section 201, the following section:- Section 201½. (a) As used in this section, the following words, unless the context clearly requires otherwise, shall have the following meanings:- “Emergency first response vehicle”, any official government motor vehicle and motorized watercraft that is intended and primarily operated to provide for the transport and rapid response of first responders to emergencies involving the public. “First responders”, members of police and fire departments, members of the state police participating in highway patrol, and members of emergency reserve units of a volunteer fire department or fire protection district, who are trained to administer an opioid antagonist pursuant to the first aid training requirements under section 201; provided, however, that first responders shall not include police officers, fire department personnel and persons engaged in police and fire work whose duties are primarily clerical or administrative. “Opioid antagonist”, as defined in section 1 of chapter 94C. (b) A governmental entity or organization shall be responsible to provide on duty first responders with an opioid antagonist for use in opioid overdose emergencies. This requirement shall be complied with by implementing 1, or any part or combination, of the following methods: (i) equipping emergency first response vehicles under its ownership, care or control with an opioid antagonist; or (ii) supplying an opioid antagonist to its first responders to be carried by such persons when on duty; provided, however, that replacement doses are made available no less than 48 hours following the administration of the last remaining dose of opioid antagonist provided by the government entity or organization to the first responder or made available in the emergency first response vehicle. (c) The requirement of a government entity or organization to provide its first responders with an opioid antagonist under this section, shall be subject to such drug’s availability, provided the government entity or organization has taken reasonable measures, as soon as practicable, to acquire and replenish its supply of an obtainable opioid antagonist to comply with this requirement. (d) No cost shall be assessed to first responders by their employing or appointing governmental entity or organization for any opioid antagonist required under this section to be supplied or made available to first responders, including any device necessary for first responders to carry the drug when on duty, which shall be provided by such entity or organization. (e) The immunity provisions established under subsection (g) of section 19B and 34A of chapter 94C shall also apply to first responders who administer an opioid antagonist. SECTION 5. Subsections (b) through (d), inclusive, of Section 4 shall take effect 8 months after the passage of this act.